Gland Pharma gets U.S. FDA nod for Sugammadex injection
The product registered U.S. sales of around $1.6 billion for the twelve months ending April 2026
· 7/29/2026, 2:58:32 PM· 2 min read
The product registered U.S. sales of around $1.6 billion for the twelve months ending April 2026
Read original story →Related stories
business
Indian young billionaires’ club gets bigger amid ageing population
business
Indian garment exporters hope for tariff-rate quota from the U.S.
business
$275mn US settlement impinges on Adani Enterprises, Q1 net loss at ₹1,160cr; but core biz remains profitable
business